Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis

Clinical trial NCT02611830 · COMPLETED

Trial details

NCT number: NCT02611830
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Colitis, Ulcerative

Start date: 2015-12-18
Primary completion: 2018-05-30
Enrollment: 383

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.